Introduction
Unless otherwise indicated, chemical reagents used in the study were purchased from Sigma Chemicals, Taufkirchen, The variable regions of Ig genes contain three complementary Germany, or from Merck AG, Darmstadt, Germany. determining regions (CDR) which code for the antigen-binding site and are unique for each B cell clone. These unique sequences have been termed idiotypes (Id). Novel molecular Cells and cell lines techniques like polymerase chain reaction (PCR) and DNA sequencing allow the rapid identification of Id DNA Mouse cell lines A20 and BCL1 (B cell lymphomas) and NS1 sequences from various human and animal B cell lymphoma.
(non-secreting myeloma) were obtained from the American These Id sequences are clinically used to identify and monitor Tissue Culture Collection (ATCC, Rockville, MD, USA). The minimal residual disease in lymphoma patients, 1,2 but also to SP6 hybridoma was obtained from Dr Axel Polack, Gesellcreate lymphoma vaccines directed against the tumor-specific schaft fü r Strahlen-und Umweltforschung (GSF), Mü nchen, Id. 3 The cloning and sequencing of these genes can also be Germany. Mononuclear cells (MNC) from patients with immunophenotypically proven CD5/CD19 positive B-CLL, or with Hodgkin's or non-Hodgkin's lymphoma were obtained by Preparation of total RNA and cDNA for consensus primer PCR Total RNA was prepared from about 5 × 10 6 cells using the Trisolv reagent (Biotecx Laboratories, Houston, TX, USA) according to the manufacturer's instructions. In brief, cells were lysed in 1 ml of the reagent by repetitive pipetting and subsequent incubation at room temperature for 5 min in Trisolv reagent. Thereafter, 200 l chloroform was added, and the homogenate was vortexed and centrifuged at 14 000 r.p.m. at 4°C for 15 min to separate the resulting three phases. The upper phase was transferred to a fresh tube, and the RNA was precipitated with 0.5 ml of isopropanol, washed with 70% ethanol, and redissolved in DPEC treated water. Oligo dT Preparation of tailed cDNA for RACE PCR and 223 (according to Kabat et al 6 ) within the CH1 domain of the respective constant region (Figures 1 and 2 ). Mouse primer Ig-specific cDNA for RACE PCR was prepared using the Gibco IgG/1 has been described previously, 4 anneals to coding BRL 5′ RACE kit according to the manufacturer's instructions. sequences for AA 212 to 222 and is degenerated to fit all IgG
In brief, 1 g of total murine RNA was incubated with subgroups. 4 Mouse primer IgM/1 was designed to bind to 2.5 pmol of primer IgA/1, IgD/1, IgG/1, or IgM/1, respectively coding sequences for AA position 195 to 205 within the IgM (IgG/1 for A20 and NS1 and IgM specific for Bcl1 and SP6) constant region. Human primer IgG/1 binds to the same and reverse transcriptase for 45 min at 42°C. One microgram coding sequences as the mouse IgG/1 primer and fits all of RNA from patients was reverse-transcribed with a mix of human IgG subgroups due to an extended sequence IgA, IgD, IgG, and IgM specific primers (2.5 pmol each) at homology in this region, whereas the IgA/1 and IgD/1 primers 42°C for 45 min. Following incubation, reverse transcriptase bind to coding sequences for AA position 203 to 213. The was heat inactivated at 70°C for 15 min. Thereafter, RNA was human IgM/1 primer was designed to bind to coding degraded by adding of 2 units of RNase H and incubating the sequences for AA position 201 to 212. Primers used for subreaction at 55°C for 10 min. The cDNA was purified by using GlassMax columns (Gibco BRL) from which it was eluted with 50 l of bidistilled water. Finally, 10 l of the resulting singlestranded cDNA was tailed in 25 l 1 × TdT buffer containing 200 M dCTP and 10 U of terminal desoxynucleotidyl transferase (Gibco BRL) for 15 min at 37°C. After heat inactivation for 10 min at 70°C, the tailed cDNA was used for PCR.
PCR
PCR was performed on a DNA Thermal Cycler 480 (Perkin Elmer, Norwalk, CT, USA) or a Thermocycler Varius 45 (Landgraf, Hannover, Germany), respectively. Typically, PCR
Figure 2
Principle of the RACE method. Total RNA was reverse was performed in a final volume of 50 l using 5 l of the transcribed, tailed and amplified as described in Materials and methods.
tailing reaction or 1 l of the Oligo dT primed cDNA. For consensus primer PCR of murine samples, DNA was amplified in 1 × Taq buffer by using 20 pmol of the appropriate forward and backward primers (see Figure 1) , 200 mol/l dNTP mix and 2.5 U Taq DNA polymerase (Stratagene, La Jolla, CA, USA). Cycling conditions were as described. 4, 5 For consensus primer PCR of human samples, 2 l of the purified, untailed cDNA (see above) was amplified using an improved protocol for Ig sequence isolation. 7 For RACE PCR, DNA was amplified in a reaction containing 20 pmol of Ig class specific primer 2, 20 pmol of the anchor primer which was supplied by the manufacturer of the RACE kit and anneals to the Oligo dC tail via G:C base pairing (see Figures 1 and 2) , 200 mol/l dNTP mix and 2.5 U Taq DNA polymerase (Stratagene). After 35
Figure 3
Comparison of consensus primer PCR and RACE PCR in cycles (1 min 94°C, 1 min 55°C, 1 min 72°C) and an different mouse cell lines. RACE PCR was performed as described in additional 10 min incubation at 72°C, 5 l aliquots were Materials and methods. In consensus primer PCR, oligo dT primed taken and analyzed on 1.5% agarose gels.
cDNA was amplified with primers published by Orlandi et al, 5 which anneal within the FR1 region of VH and the J (joining) region of the heavy chain. With these primers, amplification was possible only in Cloning and sequencing the cell lines BCL1 (B cell lymphoma) and SP6 (hybridoma), whereas a specific product could be amplified with RACE PCR in all cases.
For sequencing, 1 to 2 l of the respective PCR product was cloned into the TA cloning vector PCR 2.1 (Invitrogen NV, Leek, The Netherlands) according to the manufacturer's instructions. Individual clones were sequenced using the T7 sequencing kit (Pharmacia, Freiburg, Germany) and T7 or M13 reverse primers. Sequences were analyzed on 5% PAA gels. Alternatively, some clones were sequenced by cycle sequencing and analyzed on an automated sequencer model 377 (Applied Biosystems, Foster City, CA, USA).
Dilution experiment to determine the sensitivity of RACE PCR
The sensitivity of the RACE PCR was determined by five-fold 1:5 serial dilution of tailed cDNA obtained from LP-1 cells, with tailed cDNA obtained from HEK293 cells, and subsequent PCR amplification of the diluted samples at the conditions described above. For this purpose, 1 l of tailed LP-1 cDNA was diluted with 4 l of tailed HEK293 cDNA. 1 l of completely rearranged immunoglobulin sequences. In BCL1, Results NS1 and SP6 cells, these sequences were identical to those obtained by consensus primer PCR. Mismatches within the Amplification and sequencing of murine V H regions FR1 region of the A20 cell line (at least four mismatches in a 22 bp overlap) with consensus primers readily explained the To obtain V H sequences from different murine cell lines, we tried to amplify these sequences by consensus primer PCR failure of consensus primer PCR. Interestingly, the A20 sequence obtained by RACE PCR could not be classified into with two sets of primers published by Orlandi et al 5 and Kettleborough et al. 4 Using these primers, we were able to one of the existing murine V H subgroups as defined by a Ͼ80% sequence homology with sequences from the Kabat amplify three of the four V H sequences. With Orlandi primers, we were able to amplify the V H region of two of the four cell database (Figure 4 ). Amplification and sequencing of human V H regions primer PCR was successful with BCL1, SP6, and NS1 (data not shown), but not with A20 cells. Taken together, both Since RACE PCR was superior in identifying Id sequences in murine cell lines, we asked how efficient this method would methods failed to amplify the V H region of the A20 cell line. In contrast, it was possible to obtain a specific product from work using freshly isolated human lymphoma material. We therefore used RACE and consensus primer PCR to amplify Id all four murine cell lines with RACE PCR (Figure 3) . In all four cell lines, the resulting fragment was of the expected size sequences from the human B cell lymphoid cell line LP-1 and from tumor specimens of patients with various lymphoid (approximately 750 bp); cloning and sequencing revealed (a) RACE PCR of five patients and one cell line (LP-1, human B cell lymphoma). RNA was prepared from mononuclear cells obtained by Ficoll separation of whole blood samples (patients MM, AM, GR, KR), from a leukapheresis product after high-dose chemotherapy (patient PH) and from a lymph node (patient RS). RNA was reverse-transcribed using a mix of primers annealing within the IgA, IgD, IgG, and IgM constant regions. An oligo-dC tail was added to the 3′ end of the cDNA with terminal desoxyribonucleotidyl transferase (TdT), and finally the VH region was amplified with a primer complementary to the oligo-dC tail and IgA, IgD, IgG, and IgM-specific primers, respectively. Cloning and sequencing revealed the monoclonal proliferation of one idiotype sequence in the patients suffering from CLL (patients MM, AM, GR, KR and PH), whereas only polyclonal background was detectable in the patient RS, who suffers from a Hodgkin's lymphoma. (b) Consensus PCR of the same samples. cDNA was amplified as described. 7 Amplification was only possible in patients AM, MM, GR and KR, whereas it failed in patient PH and the LP-1 cell line. In patient RS, only a faint smear was detectable, which was typical for the amplification of polyclonal B cells. malignancies (four chronic lymphatic leukemia, one follicular 1 cells and Ig − HEK293 cells were performed as described in Material and methods. The sensitivity of RACE PCR was at lymphoma, one Hodgkin's lymphoma). Patient samples were obtained from venous blood (patients MM, AM, GR, KR), from least 1:125 cells in several experiments. This was within the same sensitivity range as standard consensus primer PCR. a leukapheresis product after high-dose chemotherapy (patient PH), or from a lymph node (patient RS). For consensus primer PCR, we used a well-established primer set 1,2,7,8 specific for the CDR3 region, and a recent protocol, which described an Discussion improved consensus primer PCR by using a proofreading polymerase. 7 With this procedure, two of the six samples This study compares two different PCR methods for amplification of murine and human immunoglobulin variable (patient PH and the LP-1 cell line) could not be amplified (see Figure 5b) . As in the case of the A20 cell line, this could be regions. The amplification of these regions with consensus primers is the current standard technique. Various sets of primers explained by mismatches of the primer annealing to the FR3 region (not shown). In all patients, the amplification of Id have been described and used during the last 7 years. 2,4,5,9-12 . However, amplification with these primers fails in 15-35%, 7 sequences was possible with RACE PCR (Figure 5 ). IgD and IgM sequences were obtained in chronic lymphocytic leukemostly due to mismatches within the PCR primer regions. These mismatches are often caused by mutations in the mia (CLL) patients, and IgG sequences in the follicular lymphoma (FL) patient. In the Hodgkin's lymphoma patient, all Ig respective regions. For example, mutations can arise after long-term immunization of mice during hybridoma cell line classes were detected. Moreover, it was possible to confirm the clonal nature of the B cell lymphoma investigated by production 13 or during progression of B cell lymphoma. 14 To overcome these primer-associated problems which arose dursequencing different clones ( Figure 6 ). In patient MM, six of eight clones sequenced had an identical sequence. This ratio ing our attempt to clone the Id sequence of the A20 cell line, 15 we designed specific primers binding to the highly conserved was 5/5 in patient AM, 7/8 in patient GR, and 6/6 in patient KR, whereas the sequences of the patient with Hodgkin's lymmouse and human heavy chain constant regions and used the 5′ RACE PCR technique originally described by Frohman et phoma (RS) revealed the expected polyclonal background. In patient PH, RACE PCR was applied to a sample obtained after al 16 to obtain full length cDNA from rare transcripts. This method allowed the amplification of the A20 Id sequence high-dose chemotherapy; in one of two clones the same sequence which was predominant in 12/12 clones before which has not been published so far. The identification of the Id DNA sequence of the A20 cell line may be of particular chemotherapy, was detected after chemotherapy, suggesting that the malignant clone had persisted after treatment and that interest, since this BALB/c cell line which was established in 1979, has been extensively used to characterize the anti-RACE PCR was able to amplify Ig sequences even from small amounts of template. In order to determine the sensitivity of idiotypic T cell response by using sublines transfected with a specific 2-cDNA.
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the RACE PCR method, serial dilution experiments using LP- Although RACE PCR has been described in 1988, only two mutations may lead to amino acid exchanges and different antigen binding properties of V H . 4 These advantages should recent reports have used this method to amplify Id sequences from the rat hybridoma ␣D11, and V H sequences isolated allow the use of RACE PCR as an optimized strategy to isolate Id sequences for the creation of tumor vaccines or for the from human multiple myelomas. 13, 18 So far, RACE PCR has not been used for murine lymphoma, where only consensus monitoring of residual disease in clonal B cell disorders, if peripheral blood or fresh or frozen biopsy material can be primer strategies have been used, 4, 5, 11 despite the fact that they fail in some cases, as shown here. Morever, RACE PCR used. Since RACE PCR needs RNA, this method is probably not applicable for paraffin-embedded material or bone marhas never been used to obtain Id sequences from freshly isolated, human B cell lymphoma material like CLL and row smears.
Though it has not been tested so far, it should be possible follicular lymphoma. The human Id sequences found could be grouped into the V H gene families V H 1 and V H 3 (see to clone RACE PCR products into appropriate eukaryotic expression vectors to produce chimeric antibodies or to create Figure 6 ). This is in accordance with previous reports showing the preferred use of V H 3 genes in CD5-positive CLL and folanti-Id vaccines by expressing these sequences in antigenpresenting cells without the need for a restriction site and an licular lymphoma. [19] [20] [21] The preferential rearrangement of the same germline V H 1 gene (from the 51P1 locus) in the other extra leader sequence at the 5′ end, since the 5′ untranslated region, start codon and leader sequence are delivered by the three patients has also been described previously in CLL patients. [22] [23] [24] RACE PCR is a promising alternative for PCR product. This could facilitate the production of specific vaccines or recombinant antibody. Experiments to use RACE detecting Id sequences in different B cell neoplasms, since we were able to amplify Id sequences in all cases studied. Finally, PCR for these purposes are currently underway. the validity of the RACE PCR method for this purpose was further demonstrated by the finding that it allowed the identification of clonal Id sequences in freshly isolated B cell non
